Literature DB >> 15714510

Pathophysiology of spastic paresis. I: Paresis and soft tissue changes.

Jean-Michel Gracies1.   

Abstract

Spastic paresis follows chronic disruption of the central execution of volitional command. Motor function in patients with spastic paresis is subjected over time to three fundamental insults, of which the last two are avoidable: (1) the neural insult itself, which causes paresis, i.e., reduced voluntary motor unit recruitment; (2) the relative immobilization of the paretic body part, commonly imposed by the current care environment, which causes adaptive shortening of the muscles left in a shortened position and joint contracture; and (3) the chronic disuse of the paretic body part, which is typically self-imposed in most patients. Chronic disuse causes plastic rearrangements in the higher centers that further reduce the ability to voluntarily recruit motor units, i.e., that aggravate baseline paresis. Part I of this review focuses on the pathophysiology of the first two factors causing motor impairment in spastic paresis: the vicious cycle of paresis-disuse-paresis and the contracture in soft tissues.

Entities:  

Mesh:

Year:  2005        PMID: 15714510     DOI: 10.1002/mus.20284

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  97 in total

1.  Primary sensory and motor cortex activities during voluntary and passive ankle mobilization by the SHADE orthosis.

Authors:  Simone Pittaccio; Filippo Zappasodi; Stefano Viscuso; Francesca Mastrolilli; Matilde Ercolani; Francesco Passarelli; Franco Molteni; Stefano Besseghini; Paolo Maria Rossini; Franca Tecchio
Journal:  Hum Brain Mapp       Date:  2011-01       Impact factor: 5.038

2.  [Botulinum toxin in the treatment of adult spasticity. An interdisciplinary German 10-point consensus 2010].

Authors:  J Wissel; M auf dem Brinke; M Hecht; C Herrmann; M Huber; S Mehnert; I Reuter; A Schramm; A Stenner; C van der Ven; M Winterholler; A Kupsch
Journal:  Nervenarzt       Date:  2011-04       Impact factor: 1.214

3.  Quantifying changes in material properties of stroke-impaired muscle.

Authors:  Sabrina S M Lee; Sam Spear; William Z Rymer
Journal:  Clin Biomech (Bristol, Avon)       Date:  2015-01-21       Impact factor: 2.063

4.  Electrodiagnostic and nerve ultrasonographic features in upper limb spasticity: an observational study.

Authors:  A Picelli; S Tamburin; G Berto; E Chemello; Marialuisa Gandolfi; Leopold Saltuari; Andreas Waldner; Nicola Smania
Journal:  Funct Neurol       Date:  2017 Jul/Sep

5.  Efficacy of photobiomodulation therapy on masseter thickness and oral health-related quality of life in children with spastic cerebral palsy.

Authors:  Maria Teresa Botti Rodrigues Santos; Karla Santos Nascimento; Simone Carazzato; Alina Oliveira Barros; Fausto Medeiros Mendes; Michele Baffi Diniz
Journal:  Lasers Med Sci       Date:  2017-05-23       Impact factor: 3.161

Review 6.  Botulinum Toxin Treatment in Multiple Sclerosis-a Review.

Authors:  Yasaman Safarpour; Tahereh Mousavi; Bahman Jabbari
Journal:  Curr Treat Options Neurol       Date:  2017-08-17       Impact factor: 3.598

7.  Validation of shear wave elastography in skeletal muscle.

Authors:  Sarah F Eby; Pengfei Song; Shigao Chen; Qingshan Chen; James F Greenleaf; Kai-Nan An
Journal:  J Biomech       Date:  2013-07-30       Impact factor: 2.712

8.  Changes in shear wave propagation within skeletal muscle during active and passive force generation.

Authors:  Allison B Wang; Eric J Perreault; Thomas J Royston; Sabrina S M Lee
Journal:  J Biomech       Date:  2019-07-25       Impact factor: 2.712

9.  Activation deficit correlates with weakness in chronic stroke: evidence from evoked and voluntary EMG recordings.

Authors:  Sheng Li; Jie Liu; Minal Bhadane; Ping Zhou; W Zev Rymer
Journal:  Clin Neurophysiol       Date:  2014-04-02       Impact factor: 3.708

10.  Comparing unilateral and bilateral upper limb training: the ULTRA-stroke program design.

Authors:  A Lex E Q van Delden; C Lieke E Peper; Jaap Harlaar; Andreas Daffertshofer; Nienke I Zijp; Kirsten Nienhuys; Peter Koppe; Gert Kwakkel; Peter J Beek
Journal:  BMC Neurol       Date:  2009-11-06       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.